Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 30, 2023
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trialVicky Coyle, Caroline Forde, Danny F McAuley, et al.
Nature|January 28, 2014
Derived immune and ancestral pigmentation alleles in a 7,000-year-old Mesolithic EuropeanIñigo Olalde, Morten E Allentoft, Federico Sánchez-Quinto, et al.
British Journal of Cancer|July 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backboneSanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott, et al.
Developmental Medicine and Child Neurology|November 17, 2022
Education and employment as young adults living with spina bifida transition to adulthood in the USA: A study of the National Spina Bifida Patient RegistryTiebin Liu, Lijing Ouyang, William O Walker, et al.
Clinical Trials (London, England)|January 27, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancerLouise C Brown, Janet Graham, David Fisher, et al.
Cancer Treatment Reviews|June 15, 2021
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysisRichard Adams, Kaitlyn Goey, Benoist Chibaudel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluationRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
American Journal of Human Genetics|December 3, 2014
A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic PopulationsFlorian J Clemente, Alexia Cardona, Charlotte E Inchley, et al.
Trials|August 31, 2017
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trialNick J Battersby, Mit Dattani, Sheela Rao, et al.
BMC Bioinformatics|December 16, 2014
COMBINE archive and OMEX format: one file to share all information to reproduce a modeling projectFrank T Bergmann, Richard Adams, Stuart Moodie, et al.
Pageof 23